News
November 7, 2025

Collaboration to support Indianapolis mothers and young children in high infant mortality neighborhoods

Jill Inderstrodt, PhD, MPH, and Katie Allen, PhD

Regenstrief to assess impact of direct cash payments on maternal and child health

Regenstrief Institute is partnering with the City of Indianapolis and other local organizations on a first‑of‑its‑kind Indianapolis initiative providing direct cash assistance over three years to low-income expectant mothers in neighborhoods with the city’s highest infant‑mortality rates.

Regenstrief’s Jill Inderstrodt, PhD, MPH, and Katie Allen, PhD, will lead the program’s evaluation component.

The $2.3 million initiative is open to Indianapolis residents 18 or older who are up to 24 weeks pregnant, have a household income of $39,000 or less, and live in the following zip codes, which experience the highest infant mortality rates in the city: 46241, 46222, 46237, 46219, 46218, 46201, and 46235.

The BRIDGE project began in New York City, is privately funded and has active and soon-to-launch initiatives in at least 16 states. The BIRTH Fund (Building Independent Resilient Thriving Homes) is locally and privately funded with support from the Indianapolis Foundation, Glick Philanthropies, Herbert Simon Family Foundation, Elevance Health and other donors.

Related News

Regenstrief Institute and Suki partner to evaluate ambient AI in healthcare

Organizations share a commitment to understanding how ambient AI technologies impact clinicians, patients and healthcare delivery  Regenstrief Institute and Suki, a

Dr. Peter J. Embi

Regenstrief’s legacy with the National Library of Medicine continues

Peter J. Embí, M.D., M.S., former president and CEO of the Regenstrief Institute, has been appointed director of the

image showing two people connecting through a kidney

Regenstrief Institute awarded KidneyX prize to advance living kidney donation

LIVINGkidney digital tool recognized in national HHS competition focused on reducing barriers for living kidney donors and transplant patients  Regenstrief

LOINC® version 2.83 enhances global health data exchange through new terminology and implementation improvements

Release expands terminology for drug and toxicology testing, microbiology, public health reporting and allergy information Regenstrief Institute has released